BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

486 related articles for article (PubMed ID: 33519714)

  • 21. Luteal-phase ovarian stimulation is a feasible method for poor ovarian responders undergoing in vitro fertilization/intracytoplasmic sperm injection-embryo transfer treatment compared to a GnRH antagonist protocol: A retrospective study.
    Wei LH; Ma WH; Tang N; Wei JH
    Taiwan J Obstet Gynecol; 2016 Feb; 55(1):50-4. PubMed ID: 26927248
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A mild ovarian stimulation strategy in women with poor ovarian reserve undergoing IVF: a multicenter randomized non-inferiority trial.
    Youssef MA; van Wely M; Al-Inany H; Madani T; Jahangiri N; Khodabakhshi S; Alhalabi M; Akhondi M; Ansaripour S; Tokhmechy R; Zarandi L; Rizk A; El-Mohamedy M; Shaeer E; Khattab M; Mochtar MH; van der Veen F
    Hum Reprod; 2017 Jan; 32(1):112-118. PubMed ID: 27836979
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The cumulative live birth rate of recombinant follicle-stimulating hormone alfa verse urinary human follicle-stimulating hormone for ovarian stimulation in assisted reproductive technology cycles.
    Yang C; Dong N; Li F; Ji Y; Pan Y; She H
    J Ovarian Res; 2022 Jun; 15(1):74. PubMed ID: 35729654
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low Serum LH Levels During Ovarian Stimulation With GnRH Antagonist Protocol Decrease the Live Birth Rate After Fresh Embryo Transfers but Have No Impact in Freeze-All Cycles.
    Luo Y; Liu S; Su H; Hua L; Ren H; Liu M; Wan Y; Li H; Li Y
    Front Endocrinol (Lausanne); 2021; 12():640047. PubMed ID: 33967956
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Progestin-Primed Ovarian Stimulation Versus Mild Stimulation Protocol in Advanced Age Women With Diminished Ovarian Reserve Undergoing Their First
    Tu X; You B; Jing M; Lin C; Zhang R
    Front Endocrinol (Lausanne); 2021; 12():801026. PubMed ID: 35140685
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dual trigger with combination of gonadotropin-releasing hormone agonist and human chorionic gonadotropin significantly improves the live-birth rate for normal responders in GnRH-antagonist cycles.
    Lin MH; Wu FS; Lee RK; Li SH; Lin SY; Hwu YM
    Fertil Steril; 2013 Nov; 100(5):1296-302. PubMed ID: 23993928
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The number of oocytes associated with maximum cumulative live birth rates per aspiration depends on female age: a population study of 221 221 treatment cycles.
    Law YJ; Zhang N; Venetis CA; Chambers GM; Harris K
    Hum Reprod; 2019 Sep; 34(9):1778-1787. PubMed ID: 31398253
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does the "delayed start" protocol with gonadotropin-releasing hormone antagonist improve the pregnancy outcome in Bologna poor responders? a randomized clinical trial.
    Ashrafi M; Arabipoor A; Yahyaei A; Zolfaghari Z; Ghaffari F
    Reprod Biol Endocrinol; 2018 Dec; 16(1):124. PubMed ID: 30593268
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cumulative live birth rates in more than 3,000 patients with poor ovarian response: a 15-year survey of final in vitro fertilization outcome.
    Xu B; Chen Y; Geerts D; Yue J; Li Z; Zhu G; Jin L
    Fertil Steril; 2018 Jun; 109(6):1051-1059. PubMed ID: 29935642
    [TBL] [Abstract][Full Text] [Related]  

  • 30. GnRH antagonist and letrozole co-treatment in diminished ovarian reserve patients: a proof-of-concept study.
    Olgan S; Humaidan P
    Reprod Biol; 2017 Mar; 17(1):105-110. PubMed ID: 28173995
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cumulative live birth rates after IVF in patients with polycystic ovaries: phenotype matters.
    De Vos M; Pareyn S; Drakopoulos P; Raimundo JM; Anckaert E; Santos-Ribeiro S; Polyzos NP; Tournaye H; Blockeel C
    Reprod Biomed Online; 2018 Aug; 37(2):163-171. PubMed ID: 29778554
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fresh
    Le TMC; Ong PT; Nguyen QA; Roque M
    JBRA Assist Reprod; 2022 Aug; 26(3):450-459. PubMed ID: 35191632
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factors affecting cumulative live birth rate after the 1st oocyte retrieved in polycystic ovary syndrome patients in women during IVF/ICSI-ET.
    Li Y; Xia L; Li Z; Zhang Z; Jiang R
    J Ovarian Res; 2023 Oct; 16(1):201. PubMed ID: 37833722
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recombinant follicle-stimulating hormone and recombinant luteinizing hormone versus recombinant follicle-stimulating hormone alone during GnRH antagonist ovarian stimulation in patients aged ≥35 years: a randomized controlled trial.
    Vuong TN; Phung HT; Ho MT
    Hum Reprod; 2015 May; 30(5):1188-95. PubMed ID: 25740882
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dual trigger with the combination of gonadotropin-releasing hormone agonist and standard dose of human chorionic gonadotropin improves
    Mutlu I; Demirdag E; Cevher F; Erdem A; Erdem M
    J Obstet Gynaecol; 2022 Jul; 42(5):1239-1244. PubMed ID: 34565274
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Triggering with human chorionic gonadotropin or a gonadotropin-releasing hormone agonist in gonadotropin-releasing hormone antagonist-treated oocyte donor cycles: findings of a large retrospective cohort study.
    Bodri D; Guillén JJ; Galindo A; Mataró D; Pujol A; Coll O
    Fertil Steril; 2009 Feb; 91(2):365-71. PubMed ID: 18367175
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Conventional ovarian stimulation and single embryo transfer for IVF/ICSI. How many oocytes do we need to maximize cumulative live birth rates after utilization of all fresh and frozen embryos?
    Drakopoulos P; Blockeel C; Stoop D; Camus M; de Vos M; Tournaye H; Polyzos NP
    Hum Reprod; 2016 Feb; 31(2):370-6. PubMed ID: 26724797
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Growth Hormone Supplementation May Not Improve Live Birth Rate in Poor Responders.
    Zhu J; Wang Y; Chen L; Liu P; Li R; Qiao J
    Front Endocrinol (Lausanne); 2020; 11():1. PubMed ID: 32038495
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of length of controlled ovarian hyperstimulation using a gonadotropin-releasing hormone antagonist on in vitro fertilization pregnancy rates.
    Royster GD; Retzloff MG; Robinson RD; King JA; Propst AM
    J Reprod Med; 2012; 57(9-10):415-20. PubMed ID: 23091989
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effectiveness of gonadotropin-releasing hormone antagonist in poor ovarian responders undergoing in vitro fertilization: a systematic review and meta-analysis.
    Xiao J; Chang S; Chen S
    Fertil Steril; 2013 Dec; 100(6):1594-601.e1-9. PubMed ID: 24055048
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.